Unilever plc ADR Dossier
|
SectorConsumer Staples IndustryPersonal Care Products Beta (adjusted)0.61 Intrinsic Value $71.60median of 6 methods · middle span $59-$97based on filings through 31 Dec 2025 Market Price $60.73Price as of 30 Sep 2026 UndervaluedIntrinsic value is 18% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $130.8B Shares Outstanding 2.2B diluted Moat Rating Wide Next Earnings Date28 Oct 2026 Last ex-dividend7 Aug 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Unilever entered the second half of 2026 with volume-led momentum: first-half underlying sales growth was 4.8%, including 4.2% volume growth, while Power Brands generated 6.0% growth and represented 78% of turnover. The operating margin reached 20.3%, and management expects full-year sales growth within 4%-6% and a modest margin improvement versus 2025. The proposed Foods combination with McCormick could sharpen Unilever into a faster-growing home-and-personal-care-focused business, but completion remains pending. A Hold is appropriate because the operating evidence is constructive while transaction execution and reported-currency effects remain material. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$70.01 Mean target$73.92 High · most bullish analyst$77.22 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $70.0122% Underlying sales growth falls below the 4% guidance floor, adverse currency continues to offset operating progress in reported turnover, or the Foods transaction ceases to be described as on track. Any combination of weaker growth, margin pressure and transaction delay would undermine the expected improvement in Unilever's growth profile. Base CaseCentral scenario $73.9257% Matches the consensus meanUnderlying sales growth remains within management's 4%-6% range, with volume near the approximately 3% full-year expectation, and underlying operating margin improves modestly from 2025. The Foods separation continues to advance but remains an execution dependency. Bull CaseUpside scenario $77.2221% First-half volume momentum persists, Power Brands continue to outgrow the group, full-year sales growth reaches the upper portion of the 4%-6% range, and margin improves despite sustained brand investment. Continued progress on the Foods combination strengthens confidence that the resulting focused business can command a better growth profile. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |